La terapia con melatonina non sopprime la sua produzione endogena nei volontari sani

Recenti Progressi in Medicina

Volumn 90, Issue 2, 1999, Pages 84-85

  Lissoni, Paolo ^a   Rovelli, Franco ^a   Pittalis, Salvatore ^a   Casati, Marco ^a   Giani, Luisa ^a   Barni, Sandro ^a   Fumagalli, Luca ^a   Laudon, Moshè ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b NEURIM PHARMACEUTICALS LTD   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ARTICLE; FEEDBACK SYSTEM; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; NORMAL HUMAN;

ADULT; CIRCADIAN RHYTHM; DARKNESS; FEMALE; HUMANS; LIGHT; MALE; MELATONIN; MIDDLE AGED; SEASONS; TIME FACTORS;

EID: 0039032271     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Jankovic BD. Neuroimmunomodulation. From phenomenology to molecular evidence. Ann NY Acad Sci 1994; 741: 1-38.
2. Weigant DA, Bla]ock JE. Interactions between the neuroendocrine and immune system: common hormones and receptors. Immunol Rev 1987; 100: 79-109.
3. Brzezinsky A. Melatonin in humans. N Engl J Med 1997; 336: 186-95.
4. Regelson W, Pierpaoli W. Melatonin: a rediscovered antitumor hormone? Cancer Invest 1987; 5: 379-85.
5. Lissoni P, Barni S, Crispino S. Tancini G, Fraschini F. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol 1989; 25: 789-95.
6. Lissoni P, Barni S, Tancini G et al. A randomised study with subcutaneous low-dose interleukin-2 alone vs interleukin-2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 1994; 69: 196-99.
7. Lissoni P, Tancini G, Barni S et al. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Supp Care Cancer 1997; 5: 126-9.
8. Arendt J. Melatonin. Clin Endocrinol 1988; 29: 205-29.